ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00319969
Recruitment Status : Completed
First Posted : April 27, 2006
Last Update Posted : September 30, 2009
Sponsor:
Information provided by:
Celgene

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2008
  Actual Study Completion Date : January 2009
  Certification/Extension First Submitted : September 28, 2009